Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-002529
Filing Date
2019-02-04
Accepted
2019-02-04 19:15:32
Documents
1
Period of Report
2019-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7346
  Complete submission text file 0000899243-19-002529.txt   8810
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Issuer) CIK: 0001103021 (see all company filings)

EIN.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1410 SMYTHE ST DANIEL ISLAND SC 29492
Business Address
Plesha Scott M. (Reporting) CIK: 0001726687 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31361 | Film No.: 19565819